Strides Pharma Science Limited (STAR.NS)
INR 615.3
(5.29%)
INR 615.3
(5.29%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.26 Billion INR | -1.77% |
| 2022 | 11.46 Billion INR | -2.33% |
| 2021 | 11.73 Billion INR | -2.24% |
| 2020 | 12 Billion INR | 53.44% |
| 2019 | 7.82 Billion INR | -10.13% |
| 2018 | 8.7 Billion INR | 57.73% |
| 2017 | 5.52 Billion INR | -25.2% |
| 2016 | 7.37 Billion INR | 20.36% |
| 2015 | 6.13 Billion INR | 195.24% |
| 2014 | 2.07 Billion INR | 18.0% |
| 2013 | 1.75 Billion INR | -60.21% |
| 2012 | 4.42 Billion INR | -7.83% |
| 2011 | 4.79 Billion INR | 53.83% |
| 2010 | 3.11 Billion INR | 33.66% |
| 2009 | 2.33 Billion INR | 34.83% |
| 2008 | 1.73 Billion INR | -13.92% |
| 2007 | 2.01 Billion INR | 63.16% |
| 2006 | 1.23 Billion INR | 41.4% |
| 2005 | 871.7 Million INR | 78.42% |
| 2004 | 488.57 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 12.1 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 11.37 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 11.26 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 11.26 Billion INR | -1.77% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 11.46 Billion INR | 0.0% |
| 2022 FY | 11.46 Billion INR | -2.33% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 11.33 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 11.73 Billion INR | -2.24% |
| 2021 Q2 | 12.28 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 11.73 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 12 Billion INR | 53.44% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 9.31 Billion INR | 0.0% |
| 2020 Q4 | 12 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 7.82 Billion INR | -10.13% |
| 2019 Q4 | 7.82 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 7.19 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 8.7 Billion INR | 57.73% |
| 2018 Q4 | 8.7 Billion INR | 0.0% |
| 2018 Q2 | 7.63 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 6.29 Billion INR | 0.0% |
| 2017 FY | 5.52 Billion INR | -25.2% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 5.52 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 7.37 Billion INR | 0.0% |
| 2016 FY | 7.37 Billion INR | 20.36% |
| 2016 Q2 | 6.86 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 6.13 Billion INR | 0.0% |
| 2015 Q2 | 2.88 Billion INR | 0.0% |
| 2015 FY | 6.13 Billion INR | 195.24% |
| 2014 FY | 2.07 Billion INR | 18.0% |
| 2014 Q4 | 2.07 Billion INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2013 FY | 1.75 Billion INR | -60.21% |
| 2012 FY | 4.42 Billion INR | -7.83% |
| 2011 FY | 4.79 Billion INR | 53.83% |
| 2010 FY | 3.11 Billion INR | 33.66% |
| 2009 FY | 2.33 Billion INR | 34.83% |
| 2008 FY | 1.73 Billion INR | -13.92% |
| 2007 FY | 2.01 Billion INR | 63.16% |
| 2006 FY | 1.23 Billion INR | 41.4% |
| 2005 FY | 871.7 Million INR | 78.42% |
| 2004 FY | 488.57 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 31.475% |
| Hester Biosciences Limited | 755.81 Million INR | -1390.11% |
| Aarti Drugs Limited | 4.85 Billion INR | -131.789% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -75.192% |
| Albert David Limited | 436.12 Million INR | -2482.403% |
| Alembic Limited | 113.4 Million INR | -9831.57% |
| Alkem Laboratories Limited | 26.61 Billion INR | 57.679% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -3699.499% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -681.904% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -44071.471% |
| Brooks Laboratories Limited | 96.1 Million INR | -11618.483% |
| Eris Lifesciences Limited | 1.89 Billion INR | -495.793% |
| FDC Limited | 3.88 Billion INR | -189.605% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -68.955% |
| Gufic Biosciences Limited | 2 Billion INR | -461.766% |
| Hikal Limited | 3.03 Billion INR | -270.815% |
| Ind-Swift Limited | 640.91 Million INR | -1657.238% |
| Innova Captab Limited | 1.44 Billion INR | -682.024% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -165.097% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -7409.769% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 12.667% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -1359.463% |
| Lupin Limited | 49.53 Billion INR | 77.266% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -810.904% |
| Medico Remedies Limited | 163.37 Million INR | -6793.715% |
| Morepen Laboratories Limited | 2.48 Billion INR | -353.044% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -58.815% |
| Orchid Pharma Limited | 2.64 Billion INR | -326.241% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -932.206% |
| RPG Life Sciences Limited | 1.01 Billion INR | -1015.089% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -28140.722% |
| Sigachi Industries Limited | 707.2 Million INR | -1492.518% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -213.105% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -387.137% |
| Themis Medicare Limited | 705.74 Million INR | -1495.822% |
| Unichem Laboratories Limited | 7.04 Billion INR | -59.824% |
| Vaishali Pharma Limited | 3.79 Million INR | -296513.116% |
| Wanbury Limited | 360.23 Million INR | -3026.43% |
| Windlas Biotech Limited | 621.89 Million INR | -1710.996% |
| ZIM Laboratories Limited | 812.62 Million INR | -1285.921% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -10669.481% |
| Ipca Laboratories Limited | 24.71 Billion INR | 54.427% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 88.587% |
| Venus Remedies Limited | 1.21 Billion INR | -825.499% |
| Sakar Healthcare Limited | 277.32 Million INR | -3961.113% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 88.517% |
| Divi's Laboratories Limited | 31.84 Billion INR | 64.628% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -394.221% |
| Mankind Pharma Limited | 15.53 Billion INR | 27.501% |
| Sequent Scientific Limited | 3.46 Billion INR | -225.285% |
| Laurus Labs Limited | 18.45 Billion INR | 38.971% |
| Neuland Laboratories Limited | 3.5 Billion INR | -221.395% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -124.123% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 55.184% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 67.279% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -3796.391% |
| Wockhardt Limited | 6.4 Billion INR | -75.975% |
| Bal Pharma Limited | 878.11 Million INR | -1182.567% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 82.278% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -850.836% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -26862.892% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | -210.225% |
| Shilpa Medicare Limited | 3.44 Billion INR | -226.514% |
| Valiant Laboratories Limited | 100.15 Million INR | -11145.083% |
| Ajanta Pharma Limited | 8.28 Billion INR | -35.96% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -3147.92% |
| Granules India Limited | 13 Billion INR | 13.402% |
| Medicamen Biotech Limited | 593.75 Million INR | -1796.819% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -5242.314% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 50.582% |
| NATCO Pharma Limited | 7 Billion INR | -60.777% |
| Suven Life Sciences Limited | 7.08 Million INR | -158861.186% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -11396.468% |
| Indoco Remedies Limited | 3.53 Billion INR | -218.994% |
| Alpa Laboratories Limited | 136.65 Million INR | -8141.605% |
| Lasa Supergenerics Limited | 190.43 Million INR | -5814.07% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -76038.453% |